220 related articles for article (PubMed ID: 35173540)
1. Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.
Shimizu S; Sunagawa Y; Hajika N; Yorimitsu N; Katanasaka Y; Funamoto M; Miyazaki Y; Sari N; Shimizu K; Hasegawa K; Morimoto T
Int J Biol Sci; 2022; 18(3):1079-1095. PubMed ID: 35173540
[TBL] [Abstract][Full Text] [Related]
2. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.
Sunagawa Y; Morimoto T; Takaya T; Kaichi S; Wada H; Kawamura T; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Biol Chem; 2010 Mar; 285(13):9556-9568. PubMed ID: 20081228
[TBL] [Abstract][Full Text] [Related]
6. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5.
Chen M; Yi B; Sun J
J Biol Chem; 2014 Aug; 289(35):24325-35. PubMed ID: 25012667
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.
Katanasaka Y; Suzuki H; Sunagawa Y; Hasegawa K; Morimoto T
Int Heart J; 2016 Dec; 57(6):672-675. PubMed ID: 27818483
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
12. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo.
van Berlo JH; Elrod JW; Aronow BJ; Pu WT; Molkentin JD
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12331-6. PubMed ID: 21746915
[TBL] [Abstract][Full Text] [Related]
13. [Development of Targeted Pharmacotherapy for Cardiovascular Disease].
Katanasaka Y
Yakugaku Zasshi; 2017; 137(11):1349-1353. PubMed ID: 29093370
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
Bisping E; Ikeda S; Sedej M; Wakula P; McMullen JR; Tarnavski O; Sedej S; Izumo S; Pu WT; Pieske B
J Biol Chem; 2012 Mar; 287(13):9827-9834. PubMed ID: 22228770
[TBL] [Abstract][Full Text] [Related]
15. Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound.
Pohjolainen L; Kinnunen SM; Auno S; Kiriazis A; Pohjavaara S; Kari-Koskinen J; Zore M; Jumppanen M; Yli-Kauhaluoma J; Talman V; Ruskoaho H; Välimäki MJ
Stem Cell Res Ther; 2024 Jan; 15(1):5. PubMed ID: 38167208
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
[TBL] [Abstract][Full Text] [Related]
19. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.
Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809
[TBL] [Abstract][Full Text] [Related]
20. TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.
Li Q; Shen P; Zeng S; Liu P
J Cardiovasc Pharmacol; 2015 Aug; 66(2):196-203. PubMed ID: 26252173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
